Drawing for VELOXIS PHARMACEUTICALS

USPTO serial 79101875

VELOXIS PHARMACEUTICALS

Reviewed by CopyMark Law Group

Reg. 4348454Status 707Registered
Filing date
Status date
Registration date
Jun 11, 2013
Examiner
GLASSER, CARYN
Law office

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with VELOXIS PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Julia Anne Matheson

Julia Anne Matheson Potomac Law Group, PLLC1300 Pennsylvania Avenue, NW, Suite 700Washington, DC 20004UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, immunotherapeutic and immunosuppressive preparations for medical use for treatment of transplant patients; pharmaceutical preparations and drug delivery systems, pharmaceutical modified drug delivery release systems, and pharmaceutical controlled drug delivery release systems, comprised of tablets, granules, pills, sachets, powders, capsules, solutions or fluids, all of the above for use in the treatment of mental and physical disorders, emergencies and traumas, aging, namely, Alzheimer's disease, arthritis, shock, immune system diseases, allergies and burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary disorders, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, gynecological diseases, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, psychiatric diseases and disorders, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions and generalized painACTIVE
040[ Treatment of materials, namely, milling, grinding, mixing, compressing, and melting of pharmaceutical, medicinal, biotechnical and bacteriological substances, preparations, formulations and solutions, for use in the pharmaceutical and medical industries ]SECTION 71 - CANCELLED
041Education and training services, namely, arranging and conducting of seminars, workshops, conferences, lectures and congresses, all in the medical, chemical and pharmaceutical fieldsACTIVE
042Scientific and technological services, namely, scientific research, analysis and testing in the field of medical science, pharmacology, biotechnology and bacteriological areas and providing consultation and information relating thereto; design of drug delivery systems for medical use; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; designing pharmaceutical medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consultation and information thereto; materials testing for the pharmaceutical and medical industriesACTIVE
044Medical and pharmaceutical assistance and consultation, namely, medical and pharmaceutical consultation, pharmaceutical advice, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticalsACTIVE
045[ Consulting in the field of intellectual property licensing; licensing of intellectual property ]SECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 8, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED
Feb 5, 2024INNPPARTIAL INVALIDATION PROCESSED BY THE IB
Jan 9, 2024INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jan 9, 2024INPCINVALIDATION PROCESSED
Nov 30, 2023INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 31, 2023NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Mar 31, 202371.PREGISTERED - PARTIAL SEC 71 ACCEPTED
Mar 30, 2023ES71TEAS SECTION 71 RECEIVED
Mar 21, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 21, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 21, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 21, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 21, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 11, 2022REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Sep 18, 2021CHLDCHANGE OF OWNER RECEIVED FROM IB
Jul 22, 2021RNWLINTERNATIONAL REGISTRATION RENEWED
May 21, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 7, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED
Dec 20, 2019INNPPARTIAL INVALIDATION PROCESSED BY THE IB
Nov 1, 2019INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Nov 1, 2019INPCINVALIDATION PROCESSED
Oct 13, 2019INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 13, 2019NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Feb 13, 2019C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Feb 12, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 6, 2019ES75TEAS SECTION 71 & 15 RECEIVED
Sep 17, 2018CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Aug 3, 2018CRCVCORRECTION TRANSACTION RECEIVED FROM IB
Jun 11, 2018REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 18, 2018ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 21, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED
Jun 26, 2015ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 11, 2014ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 7, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Sep 13, 2013FICSFINAL DISPOSITION NOTICE SENT TO IB
Sep 13, 2013FIMPFINAL DISPOSITION PROCESSED
Sep 11, 2013FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 11, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 6, 2013GPNXNOTIFICATION PROCESSED BY IB
Mar 26, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 26, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 6, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 6, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 6, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 19, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 11, 2013EXPTEXPARTE APPEAL TERMINATED
Feb 11, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 11, 2013XAECEXAMINER'S AMENDMENT ENTERED
Feb 11, 2013GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 11, 2013GNEAEXAMINERS AMENDMENT E-MAILED
Feb 11, 2013CNEAEXAMINERS AMENDMENT -WRITTEN
Jan 23, 2013GEA1NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Jan 23, 2013GECDACTION DENYING REQ FOR RECON E-MAILED
Jan 23, 2013CNCFACTION CONTINUING FINAL - COMPLETED
Jan 2, 2013EXPIEX PARTE APPEAL-INSTITUTED
Jan 2, 2013JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 2, 2013EXAFEXPARTE APPEAL RECEIVED AT TTAB
Dec 19, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 17, 2012ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 15, 2012CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Nov 14, 2012CRCVCORRECTION TRANSACTION RECEIVED FROM IB
Jul 2, 2012GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Jul 2, 2012GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 2, 2012CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 30, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 30, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 22, 2012ALIEASSIGNED TO LIE
May 10, 2012TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
May 10, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 18, 2011RFNTREFUSAL PROCESSED BY IB
Nov 10, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 4, 2011RFRRREFUSAL PROCESSED BY MPU
Nov 4, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 3, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 26, 2011DOCKASSIGNED TO EXAMINER
Sep 23, 2011MAFRAPPLICATION FILING RECEIPT MAILED
Sep 19, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 16, 2011LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 15, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance